The binding of EYA2 and DACH1 transcriptionally regulates the expression of SOCS3 and inhibits the progression of hepatocellular carcinoma by blocking the activation of the SOCS3-mediated JAK/STAT signaling pathway. Here, SOCS3 is linked to hepatocellular carcinoma.